Company attributes
Other attributes
Health Catalyst is a healthcare technology company offering a platform for organizing healthcare data from multiple systems that is headquartered in Salt Lake City, Utah and was founded in 2008 by Steven Barlow and Thomas Burton.
On September 1, 2011 Health Catalyst completed their series A funding round with an undisclosed amount of funding from Sequoia Capital.
On January 8, 2013 Health Catalyst completed their series B funding round with $33 million in funding from Norwest Venture Partners (lead investor), Sorenson Capital, and Sequoia Capital. The company plans on using the funding for investing in its technology, services, and employees.
On March 1, 2013 Health Catalyst expanded their series B funding round with $8 million in funding from Kaiser Permanente Ventures and CHV Capital.
On January 27, 2014 Health Catalyst completed their series c funding round with $41 million in funding from Sorenson Capital (lead investor), Sequoia Capital, Norwest Venture Partners, Kaiser Permanente Ventures, and CHV Capital. The company plans on using the funding for product development.
On March 17, 2015 Health Catalyst completed their series D funding round with $70 million in funding from Norwest Venture Partners (lead investor), Sands Capital Ventures, EPIC Ventures, and BYU Cougar Capital.
On February 29, 2016 Health Catalyst completed their series E funding round with $70 million in funding from UPMC (lead investor), Norwest Venture Partners (lead investor), OSF Ventures, and BYU Cougar Capital. On October 30, 2017 Health Catalyst expanded their series E funding round with $55 million in funding from Norwest Venture Partners.
On February 8, 2019 Health Catalyst completed their series F funding round with $100 million inequity and debt financing from OrbiMed (lead investor), UPMC, Sequoia Capital, Sands Capital Ventures, Norwest Ventures Partners, and Kaiser Permanente Ventures. The CEO of Health Catalyst, Thomas Burton, made the following comment regarding what the company plans on doing with their series F funding:
This additional capital will enable us to continue developing the technology and expertise necessary to offer health systems a path to systematically use data to analyze their performance, and then work to make measurable improvement in clinical, financial and operational areas.
